{"id":141261,"date":"2024-12-23T11:57:25","date_gmt":"2024-12-23T06:27:25","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=141261"},"modified":"2024-12-23T11:57:28","modified_gmt":"2024-12-23T06:27:28","slug":"pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/","title":{"rendered":"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil."},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1497914721\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>India is often referred to as the &#8220;Pharma Capital of the World&#8221; due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2639461694\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The country\u2019s robust manufacturing infrastructure, skilled workforce, and regulatory compliance make it a hub for pharmaceutical innovation and production. The CDMO sector is also rapidly growing, with India offering cost-effective and high-quality services to global pharmaceutical companies.&nbsp;<\/p><p>With increasing healthcare demands, rising chronic diseases, and expanding access to medicines, India\u2019s pharma sector is poised for significant growth. The future prospects include further expansion in exports, research and development, and biotechnology advancements.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price&nbsp;<\/strong><\/h2><p>The shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/SUVENPHAR\" target=\"_blank\" rel=\"noreferrer noopener\">Suven Pharma <\/a><\/strong>are currently trading at Rs. 1,152 down by 2.46% from its previous close of Rs. 1,185.15 as of December 23, 2024. The stock also touched an intraday low of Rs. 1,105.\u00a0<\/p><div class=\"trade-content_5\" id=\"trade-2122115493\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Update&nbsp;<\/strong><\/h2><p>Suven Pharmaceuticals Limited has successfully acquired 56% of the equity share capital of NJ Bio, Inc. (the &#8220;Target&#8221;) at an aggregate consideration of approximately INR 53.51 crore, which includes a primary equity infusion of INR 12.45 crore into NJ Bio, Inc. The acquisition was completed on December 20, 2024.&nbsp;<\/p><p>This strategic acquisition further strengthens the Company&#8217;s position in the market and enhances its capabilities. By acquiring a majority stake in NJ Bio, the Company aims to expand its portfolio and leverage the Target&#8217;s innovative technologies and growth potential. This move aligns with the Company&#8217;s long-term objectives of expanding its footprint and achieving sustainable growth in the industry.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>SPL is a Hyderabad-based Contract Development and Manufacturing Organization (CDMO) that provides comprehensive services to leading global pharmaceutical and fine chemical companies, particularly in their New Chemical Entity (NCE) development endeavors. The company offers a wide range of services, including process research and development, late-stage clinical, and commercial manufacturing. SPL is committed to delivering high-quality products that meet customer needs and expectations.&nbsp;<\/p><p>The company specializes in the development of NCE molecules and the supply of intermediates, operating in a high-value-add, high-margin business segment. SPL supplies<\/p><p>intermediates for four key molecules targeting rheumatoid diseases, demonstrating its significant role in advancing therapies for chronic conditions. With a focus on innovation and quality, SPL continues to strengthen its position in the global pharmaceutical and fine chemical markets.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By: Dipangshu Kundu&nbsp;<\/strong><\/p><\/blockquote><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-3569009721\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-2363759044\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>India is often referred to as the &#8220;Pharma Capital of the World&#8221; due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.&nbsp; The country\u2019s robust [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25688,948,936,25687,19534,19533,25689],"class_list":["post-141261","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stock-in-focus","tag-stock-market","tag-stock-market-news","tag-suven-pharma","tag-suven-pharma-acquisition","tag-suven-pharma-latest-news","tag-suven-pharmaceuticals-acquired-56-stake-in-nj-bio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil. - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"India is often referred to as the &quot;Pharma Capital of the World&quot; due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil.\" \/>\n<meta property=\"og:description\" content=\"India is often referred to as the &quot;Pharma Capital of the World&quot; due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-23T06:27:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-23T06:27:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/\",\"name\":\"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil. - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-12-23T06:27:25+00:00\",\"dateModified\":\"2024-12-23T06:27:28+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"India is often referred to as the \\\"Pharma Capital of the World\\\" due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil. - Trade Brains Features","description":"India is often referred to as the \"Pharma Capital of the World\" due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil.","og_description":"India is often referred to as the \"Pharma Capital of the World\" due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-23T06:27:25+00:00","article_modified_time":"2024-12-23T06:27:28+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/","name":"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil. - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-12-23T06:27:25+00:00","dateModified":"2024-12-23T06:27:28+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"India is often referred to as the \"Pharma Capital of the World\" due to its dominant position in the global pharmaceutical market, particularly in generic drugs and Contract Development and Manufacturing Organizations (CDMOs). India supplies over 40% of the global demand for generics, making it the largest producer of affordable medicines worldwide.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-it-acquired-56-stake-in-nj-bio-inc-for-64-mil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock in focus after it acquired 56% stake in NJ Bio Inc for $64 Mil."}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=141261"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141261\/revisions"}],"predecessor-version":[{"id":141263,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141261\/revisions\/141263"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=141261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=141261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=141261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}